• Become A Member
  • Gift Membership
  • Gift Membership
Scroll.in Logo
  • Gift Membership
  • Sign In
  • Become A Member
  • Home
  • Common Ground
  • The Latest
  • Members-Only
  • Video
  • Eco India
  • The Reel
  • Magazine
  • Trending
    Trending
    • ‘Chrislam’: In Nigeria, why two religions are better than one

      ‘Chrislam’: In Nigeria, why two religions are better than one

      Marloes Janson, The Conversation
    • In Ladakh, climate change is raining on apricots, central to life and the economy

      In Ladakh, climate change is raining on apricots, central to life and the economy

      Avidha Raha
    • Maharashtra sets up panel to examine if STs who convert to other faiths should get quota benefits

      Maharashtra sets up panel to examine if STs who convert to other faiths should get quota benefits

      Scroll Staff
    • The Indian Foreign Service built the country’s reputation. Now, it seeks awards for one leader

      The Indian Foreign Service built the country’s reputation. Now, it seeks awards for one leader

      Ashok Swain
    • Brand strategist Ambi Parameswaran reflects on the 1980-1990s, when ads focused on children

      Brand strategist Ambi Parameswaran reflects on the 1980-1990s, when ads focused on children

      Ambi Parameswaran
    • Why angry young protesters in Delhi have turned against Modi

      Why angry young protesters in Delhi have turned against Modi

      Anant Gupta
       & 
      Ayush Tiwari
    • ‘Bol Bol Rani’ review: Sai Tamhankar prevents a mind game thriller from being a brain fade

      ‘Bol Bol Rani’ review: Sai Tamhankar prevents a mind game thriller from being a brain fade

      Nandini Ramnath
    • ‘This one line is my bible – every footnote is a confession of failure’: Translator Daisy Rockwell

      ‘This one line is my bible – every footnote is a confession of failure’: Translator Daisy Rockwell

      Chintan Girish Modi
    • Why tree cutting on Dehradun highway could upend the life of a community

      Why tree cutting on Dehradun highway could upend the life of a community

      Vaishnavi Rathore
    • Supreme Court halts demolition of structures along Pakistan border for two weeks

      Supreme Court halts demolition of structures along Pakistan border for two weeks

      Scroll Staff
    • Cockroach Janta Party protest: How liberal scepticism induces paralysis in oppositional politics

      Cockroach Janta Party protest: How liberal scepticism induces paralysis in oppositional politics

      Milind Murugkar
    • ‘Fractured Communities’ by Umar Khalid: Scholarship meets commitment to marginalised lives

      ‘Fractured Communities’ by Umar Khalid: Scholarship meets commitment to marginalised lives

      Anand Teltumbde
    We Need Your Help
    Scroll has produced award-winning journalism despite threats, falling ad revenues and rising costs. Support our work. Become a member today.
  • More
    More
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Health
    • Education
    • Climate and Environment
    Newsletters
    • The Daily Brief
    • Now Watching By The Reel
    Read on the Go
    Get updates
    Please Don't Look Away
    AI is hollowing out independent media, stealing our readership and revenue. Only you can stop this bleeding. Support our work. Join Scroll today!
  • Newsletters

US FDA

  • US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths

    US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths

    Tabassum Barnagarwala
    · Apr 04, 2023 · 03:00 pm
  • Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%

    Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%

    Scroll Staff
    · Nov 05, 2021 · 06:29 pm
  • Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon

    Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon

    Scroll Staff
    · Sep 20, 2021 · 06:11 pm
  • Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin

    Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin

    Scroll Staff
    · Jun 11, 2021 · 11:51 am
  • Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator

    Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator

    Scroll Staff
    · Dec 08, 2020 · 09:31 pm
  • US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump

    US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump

    Scroll Staff
    · Nov 22, 2020 · 08:58 am
  • Coronavirus: US approves first self-testing kit, results at home within 30 minutes

    Coronavirus: US approves first self-testing kit, results at home within 30 minutes

    Scroll Staff
    · Nov 18, 2020 · 01:36 pm
  • Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine

    Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine

    Scroll Staff
    · Jun 15, 2020 · 10:55 pm
  • Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Scroll Staff
    · Aug 11, 2018 · 06:35 pm
  • Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Scroll Staff
    · Aug 11, 2018 · 05:35 pm
  • India’s largest drugmaker gets a warning letter from US FDA

    India’s largest drugmaker gets a warning letter from US FDA

    Scroll Staff
    · Dec 20, 2015 · 02:13 pm